Vanda Pharmaceuticals Inc.

Mirae Asset Global Investments Co., Ltd. VNDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/26/2026

2,872

Value ($000)

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/26/2026	25	0.0%	2,872	12/31/2025
2025 Q3	11/3/2025	11	0.0%	2,284	9/30/2025
2025 Q2	7/21/2025	11	0.0%	2,277	6/30/2025
2025 Q1	4/24/2025	9	0.0%	1,951	3/31/2025
2024 Q4	1/27/2025	9	0.0%	1,943	12/31/2024
2024 Q3	10/23/2024	10	0.0%	2,108	9/30/2024
2024 Q2	7/30/2024	10	0.0%	1,738	6/30/2024
2024 Q1	5/1/2024	185	0.0%	27,868	3/31/2024
2023 Q4	1/24/2024	116	0.0%	27,596	12/31/2023
2023 Q3	10/26/2023	119	0.0%	27,511	9/30/2023
2023 Q2	8/10/2023	231	0.0%	34,985	6/30/2023
2023 Q1	5/4/2023	246	0.0%	36,276	3/31/2023
2022 Q4	2/9/2023	204	0.0%	27,592	12/31/2022
2022 Q3	11/10/2022	239	0.0%	24,218	9/30/2022
2022 Q2	8/15/2022	187	0.0%	17,107	6/30/2022